Market Cap 272.02M
Revenue (ttm) 1.28M
Net Income (ttm) -169.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,267.97%
Debt to Equity Ratio 0.00
Volume 225,700
Avg Vol 160,832
Day's Range N/A - N/A
Shares Out 12.55M
Stochastic %K 58%
Beta 0.86
Analysts Strong Sell
Price Target $42.40

Latest News on CDTX

Cidara Therapeutics: All Stars Aligning In Favor Of CD388

May 25, 2025, 9:26 PM EDT - 11 days ago

Cidara Therapeutics: All Stars Aligning In Favor Of CD388


Cidara: Potential To Change Flu Prophylaxis Landscape With CD388

Nov 21, 2024, 3:12 PM EST - 7 months ago

Cidara: Potential To Change Flu Prophylaxis Landscape With CD388


Cidara Therapeutics Announces $105 Million Private Placement

Nov 21, 2024, 8:30 AM EST - 7 months ago

Cidara Therapeutics Announces $105 Million Private Placement


Cidara Therapeutics Announces Reverse Stock Split

Apr 22, 2024, 8:49 AM EDT - 1 year ago

Cidara Therapeutics Announces Reverse Stock Split